CC Mok

Chi-Chiu Mok is currently the chief of the Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Hong Kong.  He is a consultant physician and an honorary teaching professor of the Chinese University of Hong Kong.  Dr. Mok is the chairman of the Research Committee of his hospital and is the convener of the rheumatology service development group within the Hospital Authority of Hong Kong.  In addition, Dr. Mok serves as the program director of the Rheumatology / Immunology accreditation board of the Hong Kong College of Physicians.
An active researcher, Dr. Mok is the first author of more than 180 papers in a number of medical and Rheumatology journals including the Annals of the Rheumatic Diseases, Nature Review Rheumatology, Arthritis and Rheumatology, Rheumatology (Oxford), and Arthritis Care & Research. His research interests include systemic lupus erythematosus,
particularly lupus nephritis, and glucocorticoid induced osteoporosis.  Dr. Mok is also the principal investigator of more
than 10 phase II/III global trials investigating the safety and efficacy of novel biological agents in various rheumatic diseases.
Dr. Mok is currently the senior associate editorof the International Journal of Rheumatic Diseases and an editorial member ofthe Journal of Rheumatology, Current Rheumatology Review, Open Orthopedic Journal and Immunology and Immunogenetic Insights.  In addition, he is an ad-hoc reviewer of more than 60 medical and rheumatology journals.
Dr. Mok is a Past President of the Hong Kong Society of Rheumatology.  He is the founder editor of the Hong Kong Bulletin on Rheumatic Diseases, the official publication of the Hong Kong Society of Rheumatology.